UNSPSC 51384002: Chlorthenoxazine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C10H10ClNO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KA0B657LV3, chemically known as 4-oxo-2-(beta-chloroethyl)-2,3-dihydrobenzo-1,3-oxazine but generally known as chlorthenoxazine, which bears US NIH Compound Identifier 8602. European Medicines Agency schedules Chlorthenoxazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06214MIG.

UNSPSC 51384002 Chlorthenoxazine is a Commodity code that shows minimal alignment with recent state and local procurement activity. The single recent opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—concerns naloxone procurement and harm-reduction equipment, not chlorthenoxazine itself. The mismatch suggests either a tagging error in the source record or that chlorthenoxazine procurement through state and local channels does not appear in current solicitation activity. The Seminole County solicitation, posted June 30, 2026, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; vendors must include all shipping and delivery costs and comply with drug-free workplace and E-Verify requirements.

No additional recent opportunities under this Commodity code appear in the source. The single Seminole County record does not provide evidence of a pattern of state or local procurement activity for chlorthenoxazine or related pharmaceutical agents. Without additional current solicitations or contract awards under the code, the geographic spread and issuing-body mix cannot be characterized. The code shows little relevant recent activity in the state and local procurement market as of October 2026.